Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026)
Precision Optics Corporation (POCI) reported Cash from Financing Activities of $10.5 million for Q1 2026, up 143.66% year-over-year from $4.3 million in Q1 2025, and up 6719.76% quarter-over-quarter from -$158198.0 in Q4 2025.
Precision Optics Corporation (POCI) Cash from Financing Activities (2011 - 2026) Analysis & Trends
Precision Optics Corporation (POCI) has 16 years of Cash from Financing Activities data on file, last reported at $10.5 million in Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at $10.5 million, up 143.66% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.0 million (up 74.86% YoY), and the FY2025 annual result was $5.1 million, up 1028.44% from the prior year.
- Cash from Financing Activities rose to $10.5 million in Q1 2026 per POCI's latest filing, from -$158198.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $10.5 million in Q1 2026 and troughed at -$269019.0 in Q2 2022.
- A 5-year average of $1.1 million and a median of -$101097.0 in 2022 frame the typical range for Cash from Financing Activities.
- The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities slumped 374.57% in 2023, then surged 1531.07% in 2025.
- A 5-year view of Cash from Financing Activities shows it stood at -$101097.0 in 2022, then sank by 34.86% to -$136336.0 in 2023, then jumped by 390.21% to $395664.0 in 2024, then tumbled by 139.98% to -$158198.0 in 2025, then surged by 6719.76% to $10.5 million in 2026.
- Business Quant data shows POCI's Cash from Financing Activities at $10.5 million in Q1 2026, -$158198.0 in Q4 2025, and -$158068.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Precision Optics Corporation | 44.43 Mn | 33.75 Mn | 2.06 Mn | 10.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.47 Mn |
| Mar 31, 2026 | 10.47 Mn |
| Dec 31, 2025 | -158,198.00 |
| Dec 31, 2025 | -158,198.00 |
| Sep 30, 2025 | -158,068.00 |
| Sep 30, 2025 | -158,068.00 |
| Jun 30, 2025 | -121,267.00 |
| Jun 30, 2025 | -121,267.00 |
| Mar 31, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | 395,664.00 |
| Dec 31, 2024 | 395,664.00 |
| Sep 30, 2024 | 577,015.00 |
| Sep 30, 2024 | 577,015.00 |
| Jun 30, 2024 | 468,030.00 |
| Jun 30, 2024 | 468,030.00 |
| Mar 31, 2024 | 263,503.00 |
| Mar 31, 2024 | 263,503.00 |
| Dec 31, 2023 | -136,336.00 |
| Dec 31, 2023 | -136,336.00 |